Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout! -- Ignore unavailable to you. Want to Upgrade?

To: bluejeans who wrote (21402)	5/26/1998 1:08:00 PM
From: Phil Cressman	Read Replies (4) \| Respond to of 32384

Get real there's no way Ligand can back out of buying SRGN, an offer has been made to the shareholders and Ligand has presold or has commitments from 89% of shareholders. The only possible way for Ligand to back out would be if total misrepresentation or fraud was involved and looking at the parties involved and their advisors this is practically impossible. Consider the possibility if you must but anyone rational would dismiss entirely such a scenerio. I consider SRGN to be a nice little side play based on my feeling that LGND is currently undervalued and when the payout in shares comes it will be worth considerably more than 53 cents. The free ride along to see if the extra 23 cents in stock or cash won't cost a dime.